New Commentary in ACP Journal Club on TESTING study in IgA Nephropathy

Dr. Chi-yuan Hsu, Division Chief of UCSF Nephrology, and Dr.

Clinical trial enrollment award given to our GN team Dr. Chris Carlos and Divya Seth!

Major kudos to Dr. Christopher Carlos and our clinical research coordinator Divya Seth who received recognition from RemeGen for highest enrollment in a clinical trial for IgA Nephropathy!  

KPNC Renal Grand Rounds on Immune Checkpoint Inhibitors

UCSF GN team members Drs. Chris Carlos and Raymond Hsu were invited to give Renal Grand Rounds at Kaiser Permanente Northern California on March 24, 2022, on the topic of "Renal Complications of Immune Checkpoint Inhibitors."  It was a pleasure to collaborate and learned from seasoned nephrology...

Dr. Rolón leads webinar on new Lupus resource by GSK US

Dr. Leticia Rolón recently took part in "Lupus: Make the Link," a resource forcused on patient education and advocacy in lupus (SLE), sponsored by GSK US.  

UCSF GN team contributes to important new study on Acute Kidney Injury with Immune Checkpoint Inhibitors

Our team contributed to a new multicenter study characterizing clinical features of acute kidney injury (AKI) associated with immune checkpoint inhibitors (ICPi), including the timing, risk factors, outcomes, and re-challenge characteristics.  The study was led by our collaborators Drs.

Updates in Lupus Nephritis presented by Dr. Raymond Hsu at NKF Northern California Journal Club

Dr. Raymond Hsu presented case discussions and updates in Lupus Nephritis management at the National Kidney Foundation Northern California Journal Club on August 26, 2021. 

COVID-19 Vaccine & GN: A GlomCon Conference

Drs. Raymond Hsu, Leticia Rolon, and Anatoly Urisman presented a GomCon Conference on June 13, 2021 to an international live audience of 200+ participants. They discussed the possible association between COVID-19 vaccination and glomerular disease, and the strategies and challenges surrounding...

Dr. Kelsey Natsuhara (UCSF resident) authors new study co-mentored by Dr. Chris Carlos on predictors of kidney injury with Sorafenib in hepatocellular carcinoma

Dr. Kelsey Natsuhara, current UCSF IM resident, is lead author on a new study "Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma" in the Journal of Onco-Nephrology.  She is co-mentored by our Dr. Christopher Carlos.

UCSF Nephrology and Pathology faculty members join GlomCon's Virtual Glomerular Disease Fellowship Faculty

Drs. Leticia Rolon, Vighnesh Walavalkar, and Raymond Hsu have been invited to join the faculty of the GlomCon's Virtual Glomerular Diseases Fellowship!

Dr. Raymond Hsu named one of top 5 peer reviewers for CJASN in 2020

Dr. Raymond Hsu has been named one of five 2020 Reviewers of the Year for Clinical Journal of the American Society of Nephrology (CJASN)!